ChartRow logo
AMGN
Amgen Inc.Stock · Healthcare · Dow Jones 4.3% · Nasdaq-100 1.1% · S&P 500 0.3%
$441.44+$16.15 (+3.80%)as of Aug 19, 2:15 PM ET
CompareLLYUNHJNJISRGABBVTMO

AMGN financial statements

The full income statement, balance sheet, and cash-flow statement for Amgen Inc. (AMGN), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 537.3M2024-09 537.5M2024-12 537.2M2025-03 537.7M2025-06 538.4M2025-09 538.5M2025-12 539.1M2026-03 539.7M2026-06 540.6M+0.6% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

About this data

Source: AMGN's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all AMGN filings on SEC EDGAR → Not investment advice.